{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:08:18Z","timestamp":1790377698401,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.healun.2023.10.014","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T12:26:20Z","timestamp":1697804780000},"page":"337-345","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes"],"prefix":"10.1016","volume":"43","author":[{"given":"Samuel T.","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan K.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7536-068X","authenticated-orcid":false,"given":"Erin","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2856-6041","authenticated-orcid":false,"given":"Abbas","family":"Ardehali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.healun.2023.10.014_bib1","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.healun.2015.10.012","article-title":"Impact of donor and recipient hepatitis C status in lung transplantation","volume":"35","author":"Englum","year":"2016","journal-title":"J Hear Lung Transpl"},{"issue":"11","key":"10.1016\/j.healun.2023.10.014_bib2","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1164\/rccm.201712-2614LE","article-title":"Lung transplantation from hepatitis C viremic donors to uninfected recipients","volume":"197","author":"Abdelbasit","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.healun.2023.10.014_bib3","doi-asserted-by":"crossref","first-page":"42","DOI":"10.21037\/acs.2020.01.03","article-title":"The impact of hepatitis C viremic donor lung allograft characteristics on post-transplantation outcomes","volume":"9","author":"Woolley","year":"2020","journal-title":"Ann Cardiothorac Surg"},{"issue":"2","key":"10.1016\/j.healun.2023.10.014_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S2213-2600(19)30268-1","article-title":"Prevention of viral transmission during lung transplantation with hepatitis C-viraemic donors: an open-label, single-centre, pilot trial","volume":"8","author":"Cypel","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"17","key":"10.1016\/j.healun.2023.10.014_bib5","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.healun.2023.10.014_bib6","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.athoracsur.2021.05.010","article-title":"Outcomes of lung transplantation from hepatitis C viremic donors","volume":"113","author":"Li","year":"2022","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.healun.2023.10.014_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/0016-5085(94)90077-9","article-title":"Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C","volume":"107","author":"Fong","year":"1994","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.healun.2023.10.014_bib8","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S1053-2498(98)00019-9","article-title":"Hepatitis C virus-related fibrosing cholestatic hepatitis after cardiac transplantation: is azathioprine a contributory factor?","volume":"18","author":"Delgado","year":"1999","journal-title":"J Hear Lung Transpl"},{"key":"10.1016\/j.healun.2023.10.014_bib9","unstructured":"Scientific Registry of Transplant Recipients 2112 Public Standard Analysis Files Data Dictionary. \u3008https:\/\/www.srtr.org\/requesting-srtr-data\/saf-data-dictionary\/\u3009. Accessed June 1, 2021."},{"key":"10.1016\/j.healun.2023.10.014_bib10","unstructured":"Organ Procurement and Transplantation Network (OPTN). Policy 6: Allocation of Hearts and Heart-Lungs. \u3008https:\/\/optn.transplant.hrsa.gov\/media\/1200\/optn_policies.pdf\u3009. Published 2019. Accessed June 1, 2021."},{"issue":"5","key":"10.1016\/j.healun.2023.10.014_bib11","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/opo.12131","article-title":"When to use the Bonferroni correction","volume":"34","author":"Armstrong","year":"2014","journal-title":"Ophthalmic Physiol Opt"},{"issue":"1","key":"10.1016\/j.healun.2023.10.014_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.21037\/acs.2019.10.01","article-title":"Addressing donor-organ shortages using extended criteria in lung transplantation","volume":"9","author":"Neizer","year":"2020","journal-title":"Ann Cardiothorac Surg"},{"issue":"10","key":"10.1016\/j.healun.2023.10.014_bib13","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.healun.2022.08.007","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: thirty-ninth adult lung transplantation report\u20142022; focus on lung transplant recipients with chronic obstructive pulmonary disease","volume":"41","author":"Perch","year":"2022","journal-title":"J Hear Lung Transpl"},{"issue":"4","key":"10.1016\/j.healun.2023.10.014_bib14","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman","year":"2017","journal-title":"Am J Transpl"},{"issue":"3","key":"10.1016\/j.healun.2023.10.014_bib15","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S1053-2498(03)00148-7","article-title":"Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation","volume":"23","author":"Haji","year":"2004","journal-title":"J Hear Lung Transpl"},{"issue":"8","key":"10.1016\/j.healun.2023.10.014_bib16","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/ajt.13791","article-title":"The cell biology of cytomegalovirus: implications for transplantation","volume":"16","author":"Kaminski","year":"2016","journal-title":"Am J Transpl"},{"issue":"24","key":"10.1016\/j.healun.2023.10.014_bib17","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.1001\/jama.1989.03420240121038","article-title":"The Indirect effects of cytomegalovirus infection on the outcome of organ transplantation","volume":"261","author":"Rubin","year":"1989","journal-title":"JAMA J Am Med Assoc"},{"issue":"10","key":"10.1016\/j.healun.2023.10.014_bib18","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1016\/S2468-2667(21)00200-0","article-title":"COVID-19 pandemic and worldwide organ transplantation: a population-based study","volume":"6","author":"Aubert","year":"2021","journal-title":"Lancet Public Heal"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249823020788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249823020788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T15:14:58Z","timestamp":1762355698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249823020788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1053249823020788"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2023.10.014","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2023.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}